Search
# Popular search #
0%
# Popular search #
Stock Code
603087.SHGan & Lee Showcases Core Achievements at CPHI Worldwide 2025
Witnessed by the Brazilian Ministry of Health, Gan & Lee and Fiocruz Sign Memorandum of Understanding to Explore New Directions in Innovative Drug Cooperation
Gan & Lee Pharmaceuticals Names Dr. Ting JIA as Corporate Vice President and Chief Medical Officer to Accelerate Global Expansion of Innovative Drugs
Major Collaboration | Gan & Lee Signs National “Technology Transfer and Supply Agreement” in Brazil to Accelerate Local Insulin Manufacturing
Gan & Lee Showcases at Pharmaconex 2025, Accelerating MENA Expansion with Innovative Diabetes Solutions
Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions
To be a world-class pharmaceutical company with focus on global business development
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
This website uses cookies to give users like yourself the best possible content and experience. For more information about your choices regarding cookies, please review our Privacy Policy .
The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.
